News headlines about Sabra Healthcare REIT (NASDAQ:SBRA) have been trending somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Sabra Healthcare REIT earned a news impact score of 0.13 on Accern’s scale. Accern also gave news coverage about the real estate investment trust an impact score of 46.4131439369581 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the news articles that may have effected Accern’s rankings:
- Sabra Health Care REIT Becomes Oversold (nasdaq.com)
- 10 Attractive 5% Yields: Preferred Stocks, Bonds And Conservative Options Trades (seekingalpha.com)
- Apg Asset Management Us Inc. Increases Its Ownership in Sabra Healthcare REIT, Inc. (SBRA) Last Quarter – First News 24 (firstnewspaper24.com)
- Sabra Healthcare REIT, Inc. (SBRA) Shares Bought by Northern … – Alive For Football (aliveforfootball.com)
- Sabra Health Care REIT, Inc. Announces Third Quarter 2017 Earnings Release Date and Conference Call – GlobeNewswire (press release) (globenewswire.com)
Shares of Sabra Healthcare REIT (NASDAQ SBRA) traded up 1.38% on Friday, hitting $20.61. 1,906,602 shares of the stock traded hands. The company has a market cap of $1.35 billion, a PE ratio of 17.35 and a beta of 0.88. The stock has a 50 day moving average of $21.82 and a 200 day moving average of $23.44. Sabra Healthcare REIT has a one year low of $19.30 and a one year high of $29.10.
A number of research firms have commented on SBRA. Stifel Nicolaus reaffirmed a “hold” rating and issued a $26.00 target price on shares of Sabra Healthcare REIT in a research report on Friday, July 28th. BidaskClub raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. Zacks Investment Research raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, August 2nd. Mizuho downgraded shares of Sabra Healthcare REIT from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $25.00 to $23.00 in a research report on Monday, July 10th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and issued a $25.00 target price (down previously from $28.00) on shares of Sabra Healthcare REIT in a research report on Sunday, July 9th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $25.30.
COPYRIGHT VIOLATION NOTICE: “Sabra Healthcare REIT (SBRA) Getting Somewhat Positive Media Coverage, Study Finds” was originally reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.com-unik.info/2017/10/29/sabra-healthcare-reit-sbra-getting-somewhat-positive-media-coverage-study-finds.html.
Sabra Healthcare REIT Company Profile
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
What are top analysts saying about Sabra Healthcare REIT Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Sabra Healthcare REIT Inc. and related companies.